Titan Pharmaceuticals Inc
General ticker "TTNP" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $3.3M
Titan Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -41.8%.
Estimated limits based on current volatility of 5.7%: low 3.18$, high 3.57$
Factors to consider:
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [2.91$, 8.27$]
- 2024-12-30 to 2025-12-30 estimated range: [2.18$, 5.77$]
Financial Metrics affecting the TTNP estimates:
- Negative: Non-GAAP EPS, $ of -5.23 <= 0.10
- Negative: Operating profit margin, % of -97.53 <= 1.03
- Negative: Operating cash flow per share per price, % of -61.46 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85
- Positive: Industry inventory ratio change (median), % of -2.41 <= -0.39
Short-term TTNP quotes
Long-term TTNP plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $1.53MM | $0.56MM | $0.18MM |
| Operating Expenses | $10.88MM | $10.79MM | $7.46MM |
| Operating Income | $-9.35MM | $-10.23MM | $-7.28MM |
| Non-Operating Income | $0.58MM | $0.03MM | $1.71MM |
| Interest Expense | $0.00MM | $0.00MM | $0.00MM |
| R&D Expense | $5.69MM | $4.76MM | $1.91MM |
| Income(Loss) | $-8.78MM | $-10.21MM | $-5.57MM |
| Profit(Loss) | $-8.78MM | $-10.21MM | $-5.57MM |
| Stockholders Equity | $5.14MM | $1.36MM | $6.64MM |
| Inventory | $0.29MM | $0.11MM | $0.00MM |
| Assets | $7.99MM | $4.06MM | $8.09MM |
| Operating Cash Flow | $-7.90MM | $-8.18MM | $-7.09MM |
| Capital expenditure | $0.02MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-0.02MM | $0.00MM | $0.73MM |
| Financing Cash Flow | $8.84MM | $4.98MM | $10.00MM |
| Earnings Per Share* | $-16.68 | $-15.15 | $-7.41 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.